home / stock / frprf / frprf news
Since the invasion, my funds in Russia have been frozen. I don’t believe central banks really have the will to have very high levels of bankruptcy/unemployment/social conflict. The main concern with oil/gas companies is that the managements insist on reinvestment/growth and...
As at end June, I am +13.8% for the year, roughly matching the FTSE AS at c.12%. It has been far more volatile than is usual. Pre-Fed comments on tightening sooner than the market expected, I was up closer to 20%. The portfolio is 3% geared at present. I am open to increasing gearing ...
The following slide deck was published by 4D pharma plc in conjunction with this event. For further details see: 4D pharma (FRPRF) Investor Presentation - Slideshow
4D pharma plc (FRPRF): FY GAAP EPS of -22.80p.Revenue of £0.53M (+152.4% Y/Y)Press Release For further details see: 4D pharma plc reports FY results
Biomica released impressive pre-clinical data for its rationally designed 4 strand microbiome therapeutic candidate BMC128 in immuno-oncology presented at the 5th Annual European Microbiome Drug Development conference on January 28. BMC128 is expected to be tested in human clinical tr...
4D Pharma (DDDD.l) (FRPRF) is an under covered UK domiciled company working in the microbiome space. The company will be NASDAQ listed in Q1 of 2021. 4D Pharma seeks to understand the functions of bacteria in order to harness these functions to treat disease. 4D Pharma has produce...
I'm broadly of the view that the politicians of the leading countries will take the path-of-least-resistance and will print their way out of the crisis. 4D pharma - I have been long this since it was £2.47. It's now £1.66 but I have made money by ferociously averaging down. ...